Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis

Affiliations


Abstract

Background: Pediatric and adults patients share basic aspects of multiple sclerosis; however, pediatric patients may have distinctive clinical features and disease course.

Objective: To compare the demographic and clinical characteristics between patients of pediatric-onset and adult-onset multiple sclerosis.

Methods: Using the Kuwait National Multiple Sclerosis Registry , multiple sclerosis patients with disease onset at age ≤ 17 years (pediatric-onset multiple sclerosis) or >17 years (adult-adult multiple sclerosis) were identified. Several demographics and clinical characteristics were analyzed. Disability measures and time to reach secondary progressive multiple sclerosis were compared between the two cohorts using chi-square and Student t tests.

Results: A total of 984 records of multiple sclerosis patients were assessed, of which 111 (11.3%) had disease onset at age ≤ 17 years. The female to male ratio did not differ between the two groups (P = 0.19). The mean age at onset of pediatric- and adult-onset multiple sclerosis was 14.9 and 27.68 years, respectively. Pediatric-onset multiple sclerosis patients were more likely to have brainstem/cerebellar (P < 0.03) and multifocal (P < 0.01) presentations at onset. The mean number of relapses did not differ between the two cohorts (3.4 ± 2.1 versus 3.05 ± 2.2; P = 0.14). The mean expanded disability status scale score at last visit was lower in the pediatric-onset cohort compared with the adult-onset cohort (2.38 ± 1.72 versus 3.02 ± 2.18; P = 0.003). The time to develop secondary progressive multiple sclerosis was longer in the pediatric-onset cohort (14.6 ± 4.6 years versus 11.0 ± 5.3 years; P < 0.04).

Conclusions: Pediatric-onset multiple sclerosis patients were more likely to have brainstem/cerebellar and multifocal symptoms at onset. Although the number of relapses was comparable to the adult-onset cohort, multiple sclerosis patients with pediatric-onset had lower expanded disability status scale scores and a longer time to reach secondary progressive course at last follow-up visits.

Keywords: Kuwait; disability; multiple sclerosis; pediatric; progression.


Similar articles

Demographics and clinical characteristics of multiple sclerosis in Kuwait.

Alroughani R, Ahmed SF, Al-Hashel J.Eur Neurol. 2014;72(3-4):181-5. doi: 10.1159/000362270. Epub 2014 Sep 11.PMID: 25227152

Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.

Alroughani R, Ashkanani A, Lamdhade S.Int J Neurosci. 2012 Feb;122(2):82-7. doi: 10.3109/00207454.2011.630543. Epub 2011 Nov 15.PMID: 21985585

Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.

Alroughani RA, Akhtar S, Ahmed SF, Al-Hashel JY.Int J Neurosci. 2015;125(11):831-7. doi: 10.3109/00207454.2014.976641. Epub 2014 Nov 11.PMID: 25329929

Pediatric multiple sclerosis: analysis of clinical and epidemiological aspects according to National MS Society Consensus 2007.

Ferreira ML, Machado MI, Dantas MJ, Moreira AJ, Souza AM.Arq Neuropsiquiatr. 2008 Sep;66(3B):665-70. doi: 10.1590/s0004-282x2008000500011.PMID: 18949259

Pediatric multiple sclerosis: a review.

Alroughani R, Boyko A.BMC Neurol. 2018 Mar 9;18(1):27. doi: 10.1186/s12883-018-1026-3.PMID: 29523094 Free PMC article. Review.


Cited by

Clinical and MRI characteristics of multiple sclerosis in Iranian Children and Adolescents.

Nasehi MM, Nikkhah A, Saket S, Rezakhani S, Hosseini M, Zahed G, Alizadeh Navaei R, Moosazadeh M.Iran J Child Neurol. 2023 Winter;17(1):91-98. doi: 10.22037/ijcn.v17i1.37363. Epub 2023 Jan 1.PMID: 36721833 Free PMC article.

Cerebellar and/or Brainstem Lesions Indicate Poor Prognosis in Multiple Sclerosis: A Systematic Review.

Yang Y, Wang M, Xu L, Zhong M, Wang Y, Luan M, Li X, Zheng X.Front Neurol. 2022 Apr 29;13:874388. doi: 10.3389/fneur.2022.874388. eCollection 2022.PMID: 35572921 Free PMC article. Review.

Incidence of Pediatric Multiple Sclerosis in Iran within 2000-2019.

Nasehi MM, Nikkhah A, Moosazadeh M, Saket S, Alizadeh Navaei R.Iran J Child Neurol. 2022 Winter;16(1):31-38. doi: 10.22037/ijcn.v16i1.35572. Epub 2022 Jan 1.PMID: 35222655 Free PMC article.

Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis.

Macaron G, Feng J, Moodley M, Rensel M.Curr Treat Options Neurol. 2019 Sep 27;21(10):50. doi: 10.1007/s11940-019-0592-z.PMID: 31560095 Review.


KMEL References